title: Virosome presents multimodel cancer therapy without viral replication.
abstract: A virosome is an artificial envelope that includes viral surface proteins and lacks the ability to produce progeny virus. Virosomes are able to introduce an encapsulated macromolecule into the cytoplasm of cells using their viral envelope fusion ability. Moreover, virus-derived factors have an adjuvant effect for immune stimulation. Therefore, many virosomes have been utilized as drug delivery vectors and adjuvants for cancer therapy. This paper introduces the application of virosomes for cancer treatment. In Particular, we focus on virosomes derived from the influenza and Sendai viruses which have been widely used for cancer therapy. Influenza virosomes have been mainly applied as drug delivery vectors and adjuvants. By contrast, the Sendai virosomes have been mainly applied as anticancer immune activators and apoptosis inducers.
authors.affiliation: Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
authors.forename: Kotaro
authors.initials: K
authors.lastname: Saga
authors.affiliation: Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
authors.forename: Yasufumi
authors.initials: Y
authors.lastname: Kaneda
mesh_terms: D016503:Drug Delivery Systems; D006801:Humans; D009980:Influenza A virus / Q000737:chemistry / Q000235:genetics; D008565:Membrane Proteins; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D022701:Virosomes / Q000008:administration & dosage* / Q000235:genetics
chemical_list: D008565:Membrane Proteins; D022701:Virosomes